Neuraminidase inhibitors for preventing and treating influenza in children (published trials only) - Test2 - elhamkhani - TriplyDB

Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)

Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)

http://www.wikidata.org/entity/Q24200222

about

The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews Chinese medicinal herbs for influenza Homeopathic Oscillococcinum ® for preventing and treating influenza and influenza-like illness Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments Virus-induced secondary bacterial infection: a concise review Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context.Differential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in Germany Antiviral Medications in Seasonal and Pandemic Influenza.The burden of seasonal and pandemic influenza in infants and children.Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports In-silico structural analysis of the influenza A subtype H7N9 neuraminidase and molecular docking with different neuraminidase inhibitors.Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management.Influenza vaccines and vaccinations in Poland - past, present and future.Protecting pediatric oncology patients from influenza Prevention of influenza in healthy children.Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.A prospective observational study of oseltamivir safety and tolerability in infants and young children ≤24 months.La pneumonie non compliquée chez les enfants et les adolescents canadiens en santé : points de pratique sur la prise en charge.Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.

P2860

Q21090775-4CECE3DC-BA22-41D3-A24F-5CBB4B8E6B07 Q24199132-64272F60-AF71-4511-982A-C896ED09A184 Q24202549-362DB37C-1726-4703-B4DE-00BEBFE4E46B Q24568340-BC159F42-6DBC-4593-9F38-B5DF411C53A6 Q26783333-C70CF1B2-2120-4417-B906-62A6FEE46516 Q27021579-FEAED776-B1A5-4910-93AD-D67003B051FD Q30151721-EEC16A56-E5C6-4043-A18C-CE16998324F5 Q30352949-1947945E-2B91-4E45-949A-F95972DD9F2D Q30396994-BE8C93DD-3AD4-4BA3-9E6B-CC12373537E3 Q30430303-C24D2A10-EBA5-4CE8-BF39-3932E64D1CD2 Q34264254-DD7AE1C8-ACE1-413D-AF08-CBF0AAC2DA47 Q36097702-C2BC27D1-5C3B-4256-98EF-13316C7E8E9F Q36425466-AD4C9026-B077-42F9-9038-EA3CE7644D9B Q36576966-005EF582-36B4-4E3A-AC26-BA0A1DD14FD2 Q36630470-90BE0D74-6B84-413C-99B5-AAD2B36EA175 Q37147720-251A35F2-2C9A-4AF2-8DA6-1C6E82F7CCC2 Q37688511-28FB1D79-A3D2-4CD4-88EA-6507572AF491 Q41694420-79796CF1-42C7-4859-90E4-470C892E96E8 Q46486735-D14CBEC9-DC58-40B0-91E9-4397AD2DCE67 Q47611417-6F155FE7-1AA4-48B3-B5E8-771CF0D83D8F

P2860

Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)

http://www.wikidata.org/entity/Q24200222

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Neuraminidase inhibitors for p ...... ildren (published trials only)

@ast

Neuraminidase inhibitors for p ...... ildren (published trials only)

@en

Neuraminidase inhibitors for p ...... ildren (published trials only)

@en-gb

Neuraminidase inhibitors for p ...... ildren (published trials only)

@nl

type

label

Neuraminidase inhibitors for p ...... ildren (published trials only)

@ast

Neuraminidase inhibitors for p ...... ildren (published trials only)

@en

Neuraminidase inhibitors for p ...... ildren (published trials only)

@en-gb

Neuraminidase inhibitors for p ...... ildren (published trials only)

@nl

prefLabel

Neuraminidase inhibitors for p ...... ildren (published trials only)

@ast

Neuraminidase inhibitors for p ...... ildren (published trials only)

@en

Neuraminidase inhibitors for p ...... ildren (published trials only)

@en-gb

Neuraminidase inhibitors for p ...... ildren (published trials only)

@nl

P1433

Q24200222-5DD13755-ADC2-4C60-8655-BCED97A038B0

P1476

Q24200222-950D8DA3-E2A4-4EBD-AC3E-6E6C226B00EB

P2093

Q24200222-3E11AC34-FB6D-4461-B025-B73176C4766A

Q24200222-427C687F-BEBA-4022-A7A6-1D3EB5D724D2

Q24200222-BB863396-ACAD-4A84-8109-24DB17F40F0E

Q24200222-D8648333-404D-4D1B-A41E-DB3ED84A883F

Q24200222-E169EF88-0666-4A24-81DC-857C4B566F51

P2860

Q24200222-050D0811-5D2B-4C1F-8276-A1BD4C37332D

Q24200222-0523922D-C1C7-4668-952D-6A0DE21D984C

Q24200222-056390A9-1333-4D0D-A884-53A081F2FF5A

Q24200222-06D834B8-877B-4709-B854-9C6DEE7A0BBE

Q24200222-0CA29587-9488-4D17-8977-82ED11816BA1

Q24200222-0F1D0FDF-A7CF-4A62-B6E2-DE29CED09BDD

Q24200222-13DA0869-54BA-475A-B1F9-DF639B4969FF

Q24200222-1C0516D5-1EE7-4B3D-BCD0-FFB95560BFA5

Q24200222-1F9026F5-715D-4EC4-A9EE-BAE2189C8121

Q24200222-22E06C18-8619-4C62-9C3F-28FF82F99016

P304

Q24200222-106C7042-8560-4A3E-AB11-7AF263BC7DAD

P31

Q24200222-1063CDDD-AD9F-41FB-A039-93AA839BAB19

Q24200222-be979b4f-7868-4a7f-990e-55579e40b678

P3181

Q24200222-EECB2A3D-3F1C-4B05-8916-0BF2846B2256

P356

Q24200222-937793E3-B1ED-4526-8BA1-076FD3650033

P433

Q24200222-428D9AEA-F104-4A53-8B30-2F9C71355958

P577

Q24200222-D92B73AB-83C1-478E-8998-4FBF08A7C8AA

P698

Q24200222-ACC91347-2A19-4465-9F4F-D6952A3DCA21

P932

Q24200222-0F053613-5CCE-41E9-B22F-F3504D376BAF

P3181

P356

14651858.CD002744.PUB4

P1433

Cochrane Database of Systematic Reviews

P1476

Neuraminidase inhibitors for p ...... ildren (published trials only)

@en

P2093

Anthony Harnden

http://www.w3.org/2001/XMLSchema#string

Kay Wang

http://www.w3.org/2001/XMLSchema#string

Matthew Shun-Shin

http://www.w3.org/2001/XMLSchema#string

Peter Gill

http://www.w3.org/2001/XMLSchema#string

Rafael Perera

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review of influenza resistance to the neuraminidase inhibitors

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children

Neuraminidase inhibitors for preventing and treating influenza in children

Time to publication for results of clinical trials

Amantadine and rimantadine for influenza A in adults

CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity

Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma

Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.

P304

CD002744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3064052

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD002744.PUB4

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22513907

http://www.w3.org/2001/XMLSchema#string

P932

6599832

http://www.w3.org/2001/XMLSchema#string